Related Experiment Videos
TGF-beta and colorectal carcinogenesis
1Department of Surgery, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, USA.
Abstract:
There is substantial evidence to support the contention that the Smad portion of the TGF-beta signal transduction pathway provides an important tumor-suppressor function. Mutational loss of function of Smad pathway members have been associated with the development of human cancers and appear to be causative in selected rodent carcinogenesis models. TGF-beta also has multiple other actions that appear to be independent of the growth-inhibitory/tumor suppressor effects. The predominant effect of TGF-beta appears to be dependent on the context of the responding cell. Once transformation has occurred, TGF-beta effects may be detrimental and may actually promote tumor cell survival, invasion, and metastasis. Recent work suggests that these effects may involve TGF-beta regulation of COX-2 and other pathways that may contribute to tumor cell aggressiveness. In gaining a better understanding of the mechanisms by which TGF-beta may promote tumor progression, it is likely that new therapeutic strategies may be developed that preserve tumor-suppressor function of TGF-beta while inhibiting the tumor-promoting effects.
Insights
Transforming growth factor-beta (TGF-beta) signaling has a dual role in cancer. While Smad proteins suppress tumors, TGF-beta can promote cancer progression and metastasis in later stages.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Smad pathway is crucial for the tumor-suppressor function of Transforming Growth Factor-beta (TGF-beta).
- Loss-of-function mutations in Smad pathway members are linked to human cancers and rodent carcinogenesis.
- TGF-beta exhibits context-dependent effects, with roles extending beyond growth inhibition.
Purpose of the Study:
- To elucidate the dual role of TGF-beta signaling in cancer development and progression.
- To understand how TGF-beta influences tumor cell survival, invasion, and metastasis.
- To identify mechanisms for developing targeted cancer therapies.
Main Methods:
- Review of existing evidence on Smad pathway function in carcinogenesis.
- Analysis of TGF-beta's context-dependent effects on cellular transformation.
- Investigation of TGF-beta's regulation of pathways like COX-2 in aggressive tumors.
Main Results:
- TGF-beta's Smad-dependent actions primarily act as tumor suppressors.
- In advanced cancers, TGF-beta can promote tumor cell survival, invasion, and metastasis.
- TGF-beta's tumor-promoting effects may involve regulation of COX-2 and other pathways.
Conclusions:
- Understanding the dual role of TGF-beta is critical for cancer therapy.
- Therapeutic strategies should aim to preserve TGF-beta's tumor-suppressor functions.
- Inhibiting TGF-beta's tumor-promoting effects may offer new treatment avenues.